NIH sponsors the trial of monoclonal antibody to prevent asthma exacerbations in urban youth

By | June 2, 2022
The National Institutes of Health has launched a clinical trial testing whether a monoclonal antibody, dupilumab, can reduce asthma attacks and improve lung function and asthma symptoms in children with poorly controlled allergic asthma who live in low-income urban neighborhoods.